Clozapine-induced double incontinence [2]

Indian Journal of Medical Sciences

Volumn 61, Issue 12, 2007, Pages 665-666

  Mendhekar, D ^a,c   Duggal, H ^b  

^a Neuropsychiatry and Headache Clinic   (India)

^b Herrick Memorial Hospital   (United States)

^c NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CLOZAPINE; NEUROLEPTIC AGENT; PHENYLEPHRINE;

ADULT; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFECT; DRUG INDUCED DISEASE; FECES INCONTINENCE; HUMAN; INCONTINENCE; LETTER; MALE; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TREATMENT OUTCOME; URINE INCONTINENCE;

EID: 38149062891     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.37788     Document Type: Letter

References (5)

1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reaction. Clin Pharmacol Ther 1981;30:239-45.
2. Sagar R, Varghese ST, Balhara YP. Olanzapine-induced double incontinence. Indian J Med Sci 2005;59:163-4.
3. Speakman CT, Hoyle CH, Kamin MA, Henry MM, Nicholls RJ, Burnstock G. Adrenergic control of the internal anal sphincter is abnormal in patients with idiopathic fecal incontinence. Br J Surg 1990;77:1342-4.
4. Cheetham MJ, Kamm MA, Phillips RK. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001;48:356-9.
5. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine-induced urinary incontinence: Incidence and treatment with ephedrine. J Clin Psychiatry 1996;57:514-8.